Featured
-
-
-
Article
| Open AccessOesophageal cancer awareness and anticipated time to help-seeking: results from a population-based survey
- Jasmijn Sijben
- , Lotte J. Huibertse
- & Peter D. Siersema
-
Article |
Prediction of response to neoadjuvant chemo-immunotherapy in patients with esophageal squamous cell carcinoma by a rapid breath test
- Qi Huang
- , Zheng Liu
- & Xiangnan Li
-
Article
| Open AccessCancer-related fatigue trajectories up to 5 years after curative treatment for oesophageal cancer
- Zhao Cheng
- , Asif Johar
- & Pernilla Lagergren
-
Article |
Dexamethasone-sparing on days 2–4 with combined palonosetron, neurokinin-1 receptor antagonist, and olanzapine in cisplatin: a randomized phase III trial (SPARED Trial)
- Hiroko Minatogawa
- , Naoki Izawa
- & Takako Eguchi Nakajima
-
Review Article
| Open AccessTotal neoadjuvant therapy in oesophageal and gastro-oesophageal junctional adenocarcinoma
- Hollie A. Clements
- , Tim J. Underwood
- & Russell D. Petty
-
Article |
Tertiary lymphoid structures correlate with enhancement of antitumor immunity in esophageal squamous cell carcinoma
- Shoichi Nakamura
- , Kenoki Ohuchida
- & Masafumi Nakamura
-
Correspondence |
Pan-cancer analysis of TRPV2 identifies its potential role as a prognostic and immunologic biomarker in oesophageal cancer
- Hang Yi
- , Yiwen Lin
- & Yousheng Mao
-
Article |
Chemoradiotherapy versus triplet chemotherapy as initial therapy for T4b esophageal cancer: survival results from a multicenter randomized Phase 2 trial
- Makoto Yamasaki
- , Hiroshi Miyata
- & Yuichiro Doki
-
Article
| Open AccessDensity and maturity of peritumoral tertiary lymphoid structures in oesophageal squamous cell carcinoma predicts patient survival and response to immune checkpoint inhibitors
- Yoshinori Hayashi
- , Tomoki Makino
- & Yuichiro Doki
-
Article |
Combined regression score predicts outcome after neoadjuvant treatment of oesophageal cancer
- A. I. Damanakis
- , F. Gebauer
- & W. Schroeder
-
Article
| Open AccessPathological regression of primary tumour and metastatic lymph nodes following chemotherapy in resectable OG cancer: pooled analysis of two trials
- Avani Athauda
- , Matthew Nankivell
- & Heike I. Grabsch
-
Article
| Open AccessRisk stratification of oesophageal squamous cell carcinoma using change in total lesion glycolysis and number of PET-positive lymph nodes
- Yohei Nose
- , Tomoki Makino
- & Yuichiro Doki
-
Article
| Open AccessPredicting the HER2 status in oesophageal cancer from tissue microarrays using convolutional neural networks
- Juan I. Pisula
- , Rabi R. Datta
- & Katarzyna Bozek
-
Article |
Intratumour Fusobacterium nucleatum and immune response to oesophageal cancer
- Keisuke Kosumi
- , Yoshifumi Baba
- & Hideo Baba
-
Article |
The future burden of oesophageal and stomach cancers attributable to modifiable behaviours in Australia: a pooled cohort study
- Maarit A. Laaksonen
- , Siqi Li
- & Claire M. Vajdic
-
Article
| Open AccessClonal relationship and alcohol consumption-associated mutational signature in synchronous hypopharyngeal tumours and oesophageal squamous cell carcinoma
- Josephine Mun-Yee Ko
- , Chen Guo
- & Maria Li Lung
-
Article |
A liquid biopsy signature predicts lymph node metastases in T1 oesophageal squamous cell carcinoma: implications for precision treatment strategy
- Liyan Xue
- , Zitong Zhao
- & Yongmei Song
-
Review Article |
Immunotherapy use in oesophagogastric cancers—a review of the literature
- Annabel Smith
- , Amitesh Roy
- & Timothy Price
-
Review Article
| Open AccessAdvances in the curative management of oesophageal cancer
- Jarlath C. Bolger
- , Claire L. Donohoe
- & John V. Reynolds
-
Article |
Menopausal hormone therapy and risk of oesophageal adenocarcinoma in a population-based cohort study
- Shao-Hua Xie
- , Giola Santoni
- & Jesper Lagergren
-
Article |
APR-246 induces apoptosis and enhances chemo-sensitivity via activation of ROS and TAp73-Noxa signal in oesophageal squamous cell cancer with TP53 missense mutation
- Teruyuki Kobayashi
- , Tomoki Makino
- & Yuichiro Doki
-
Article
| Open AccessAspirin enhances the therapeutic efficacy of cisplatin in oesophageal squamous cell carcinoma by inhibition of putative cancer stem cells
- Zhigeng Zou
- , Wei Zheng
- & Xiying Yu
-
Review Article
| Open AccessResistance to immune checkpoint inhibitors in advanced gastro-oesophageal cancers
- Mark A. Baxter
- , Fearghas Middleton
- & Russell D. Petty
-
Article |
Porphyromonas gingivalis infection exacerbates oesophageal cancer and promotes resistance to neoadjuvant chemotherapy
- Shegan Gao
- , Yiwen Liu
- & Huizhi Wang
-
Article |
Identification of diagnostic markers and lipid dysregulation in oesophageal squamous cell carcinoma through lipidomic analysis and machine learning
- Yuyao Yuan
- , Zitong Zhao
- & Yuxin Yin
-
Comment |
Personalising care in oesophageal cancer care with liquid biopsy
- Bruno De Paula
- & Elizabeth C Smyth
-
Article |
Does a high Mandard score really define a poor response to chemotherapy in oesophageal adenocarcinoma?
- William R. C. Knight
- , Cara R. Baker
- & J. Meenan
-
Article
| Open AccessFusobacterium nucleatum confers chemoresistance by modulating autophagy in oesophageal squamous cell carcinoma
- Yang Liu
- , Yoshifumi Baba
- & Hideo Baba
-
Editorial
| Open AccessCombining precision medicine and prophylaxis in oesophageal squamous cell carcinoma
- Mark A. Baxter
- , Lindsay C. Spender
- & Russell D. Petty
-
Article
| Open AccessChemoradiotherapy with extended nodal irradiation and/or erlotinib in locally advanced oesophageal squamous cell cancer: long-term update of a randomised phase 3 trial
- Congying Xie
- , Zhao Jing
- & Shixiu Wu
-
Article
| Open AccessIsocitrate dehydrogenase 2 contributes to radiation resistance of oesophageal squamous cell carcinoma via regulating mitochondrial function and ROS/pAKT signalling
- Xuan Chen
- , Shichao Zhuo
- & Yufeng Cheng
-
Article
| Open AccessAssociations between calcium and magnesium intake and the risk of incident oesophageal cancer: an analysis of the NIH-AARP Diet and Health Study prospective cohort
- Shailja C. Shah
- , Qi Dai
- & Martha J. Shrubsole
-
Article
| Open AccessRelationship between the immune microenvironment of different locations in a primary tumour and clinical outcomes of oesophageal squamous cell carcinoma
- Ken Hatogai
- , Satoshi Fujii
- & Atsushi Ochiai
-
Article
| Open AccessPost-neoadjuvant cellular dissociation grading based on tumour budding and cell nest size is associated with therapy response and survival in oesophageal squamous cell carcinoma
- Moritz Jesinghaus
- , Melanie Boxberg
- & Wilko Weichert
-
Perspective
| Open AccessIngested asbestos in filtered beer, in addition to occupational exposure, as a causative factor in oesophageal adenocarcinoma
- Rebecca C. Fitzgerald
- & Jonathan M. Rhodes
-
Article
| Open AccessNut consumption and the risk of oesophageal squamous cell carcinoma in the Golestan Cohort Study
- Maryam Hashemian
- , Gwen Murphy
- & Reza Malekzadeh
-
Article
| Open AccessMASAN: a novel staging system for prognosis of patients with oesophageal squamous cell carcinoma
- Wei Liu
- , Jian-zhong He
- & Li-yan Xu
-
Article
| Open AccessTrends and projections in adenocarcinoma and squamous cell carcinoma of the oesophagus in England from 1971 to 2037
- Judith Offman
- , Francesca Pesola
- & Peter Sasieni
-
Clinical Study
| Open AccessInfluence of induction chemotherapy in trimodality therapy-eligible oesophageal cancer patients: secondary analysis of a randomised trial
- Yusuke Shimodaira
- , Rebecca S Slack
- & Jaffer A Ajani
-
Genetics and Genomics
| Open AccessDisseminated tumour cells with highly aberrant genomes are linked to poor prognosis in operable oesophageal adenocarcinoma
- Sarah Schumacher
- , Christoph Bartenhagen
- & Birte Möhlendick
-
Translational Therapeutics
| Open AccessNuclear expression of Gli-1 is predictive of pathologic complete response to chemoradiation in trimodality treated oesophageal cancer patients
- Roopma Wadhwa
- , Xuemei Wang
- & Jaffer A Ajani
-
Clinical Study
| Open AccessHamburg-Glasgow classification: preoperative staging by combination of disseminated tumour load and systemic inflammation in oesophageal carcinoma
- Matthias Reeh
- , Tarik Ghadban
- & Yogesh K Vashist
-
Clinical Study
| Open AccessNomogram-based prediction of survival in patients with advanced oesophagogastric adenocarcinoma receiving first-line chemotherapy: a multicenter prospective study in the era of trastuzumab
- A Custodio
- , A Carmona-Bayonas
- & J Gallego
-
Epidemiology
| Open AccessBody weight trajectories and risk of oesophageal and gastric cardia adenocarcinomas: a pooled analysis of NIH-AARP and PLCO Studies
- Jessica L Petrick
- , Scott P Kelly
- & Michael B Cook
-
Clinical Study
| Open AccessLong-term results and recurrence patterns from SCOPE-1: a phase II/III randomised trial of definitive chemoradiotherapy +/− cetuximab in oesophageal cancer
- T Crosby
- , C N Hurt
- & S Mukherjee
-
Molecular Diagnostics
| Open AccessmiR-146a-5p mediates epithelial–mesenchymal transition of oesophageal squamous cell carcinoma via targeting Notch2
- Cong Wang
- , Wenxue Zhang
- & George M Yousef
-
Clinical Study
| Open AccessPhase II study of chemoselection with docetaxel plus cisplatin and 5-fluorouracil induction chemotherapy and subsequent conversion surgery for locally advanced unresectable oesophageal cancer
- Tomoya Yokota
- , Ken Kato
- & Yuko Kitagawa
-
Epidemiology
| Open AccessPathogenesis and progression of oesophageal adenocarcinoma varies by prior diagnosis of Barrett’s oesophagus
- Michael B Cook
- , Jennifer Drahos
- & Christian C Abnet